StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
130
This month
3
This week
2
This year
14
Publishing Date
2024 - 01 - 16
2
2023 - 11 - 21
2
2023 - 09 - 22
2
2023 - 07 - 21
2
2023 - 06 - 02
1
2023 - 06 - 01
1
2023 - 05 - 18
1
2023 - 05 - 16
2
2023 - 05 - 09
2
2023 - 05 - 05
1
2023 - 05 - 04
1
2023 - 05 - 03
8
2023 - 05 - 02
3
2023 - 05 - 01
8
2023 - 04 - 25
1
2023 - 04 - 19
1
2023 - 04 - 13
1
2023 - 04 - 10
1
2023 - 04 - 04
1
2023 - 03 - 21
1
2023 - 03 - 03
1
2023 - 02 - 27
1
2023 - 02 - 23
1
2023 - 02 - 09
1
2023 - 01 - 30
2
2023 - 01 - 26
1
2023 - 01 - 12
1
2022 - 12 - 15
1
2022 - 12 - 08
2
2022 - 11 - 29
1
2022 - 11 - 08
1
2022 - 11 - 02
1
2022 - 11 - 01
1
2022 - 10 - 05
1
2022 - 09 - 30
1
2022 - 09 - 28
1
2022 - 08 - 31
1
2022 - 08 - 24
2
2022 - 08 - 08
2
2022 - 07 - 27
1
2022 - 07 - 01
1
2022 - 06 - 29
2
2022 - 04 - 19
2
2022 - 04 - 07
1
2022 - 03 - 30
1
2022 - 02 - 23
1
2022 - 01 - 18
1
2021 - 12 - 21
1
2021 - 11 - 26
1
2021 - 11 - 18
2
2021 - 11 - 11
1
2021 - 11 - 10
1
2021 - 11 - 09
1
2021 - 11 - 08
1
2021 - 11 - 05
1
2021 - 10 - 29
1
2021 - 10 - 21
1
2021 - 10 - 20
1
2021 - 10 - 07
1
2021 - 10 - 05
1
Sector
Communications
2
Consumer services
2
Electronic technology
3
Finance
2
Health services
2
Health technology
130
Manufacturing
7
Miscellaneous
2
N/a
12
Process industries
2
Producer manufacturing
1
Professional, scientific, and technical services
1
Retail trade
3
Technology services
3
Utilities
1
Tags
Abbvie
1
Achondroplasia
1
Acquire
1
Acquisition
4
Active
3
Advanced
1
Alliances
3
America
6
Anemia
1
Approval
3
Approved
5
Awards
2
Biotech-bay
3
Breast
3
Canada
2
Cancer
9
Cell
4
Children
2
Companies
4
Corporation
2
Deal
2
Diabetes
2
Disease
2
Drug
8
Dupixent
4
Earnings
2
Expected
3
Fda
8
Financial
6
Financial results
2
Genetown
3
Global
14
Growth
25
Impact
2
Influenza
3
Iot
2
Key
4
Lung
2
Market
46
Money
2
N/a
100
Pharm-country
2
Positive
7
Rapid
2
Rare
5
Reach
4
Regulatory
3
Report
13
Research
4
Results
17
Sanofi
4
Set
3
Study
10
Therapeutics
13
Therapy
2
Tiger
2
Treatment
9
Update
3
Vaccine
7
Year
6
Entities
3m company
1
Abbott laboratories
6
Abbvie inc.
10
Acadia pharmaceuticals inc.
1
Adverum biotechnologies, inc.
1
Albemarle corporation
1
Aldeyra therapeutics, inc.
1
Allakos inc.
1
Alnylam pharmaceuticals, inc.
5
Alphabet inc.
2
Alpine immune sciences, inc.
1
Amarin corporation plc
1
Amgen inc.
8
Apple inc.
2
Applied genetic technologies corporation
3
Arcturus therapeutics holdings inc.
1
Arcus biosciences, inc.
1
Arrowhead pharmaceuticals, inc.
1
Astellas pharma inc
2
Astrazeneca plc
5
Avantor, inc.
1
Avista public acquisition corp. ii
1
Axsome therapeutics, inc.
1
Bausch health companies inc.
2
Baxter international inc.
2
Becton, dickinson and company
1
Bio-rad laboratories, inc.
1
Biogen inc.
1
Biomarin pharmaceutical inc.
3
Biontech se
1
Blueprint medicines corporation
1
Bristol-myers squibb company
6
Eli lilly and company
15
Glaxosmithkline plc
15
Immutep limited
2
Inovio pharmaceuticals, inc.
2
Johnson & johnson
18
Kimbell royalty partners
2
Kimbell tiger acquisition corp
3
Ligand pharmaceuticals incorporated
5
Mobiv acquisition corp
7
Novartis ag
16
Novo nordisk a/s
5
Nurix therapeutics, inc.
2
Orange
2
Perrigo company
2
Pfizer, inc.
3
Provention bio, inc.
21
Rcf acquisition corp.
8
Regeneron pharmaceuticals, inc.
8
Regenxbio inc.
2
Roth ch acquisition v co.
2
Sanofi
130
Takeda pharmaceutical company limited
5
Terumo corp
2
Teva pharmaceutical industries ltd
15
Thermo fisher scientific inc
4
Ucb s.a.
2
Viatris inc.
8
Xeriant, inc.
2
Symbols
AAPL
42
ABB
58
ABBV
37
ABLZF
45
ABT
74
ACAQ
51
AEM
40
AMGN
47
ARVL
157
AUY
33
BDX
37
CLLS
37
CNS
46
CNXC
36
DHR
40
DOV
37
ENB
32
ERIC
34
EXPR
31
FNCTF
302
FRBA
44
FST
41
GE
36
GIC
31
GLAXF
34
GOOG
46
GOOGL
46
GSK
48
HON
60
HUBS
58
JNJ
166
LLY
70
LMNR
39
LTUM
47
LYV
31
MDC
52
MDT
46
MFC
64
MMM
38
MS
301
NBR
34
NDAQ
50
NVDA
37
NVS
55
NVSEF
43
OOMA
68
ORCL
32
PPRUF
41
PPRUY
41
SAP
43
SLG
39
SNOW
52
SNY
159
SNYNF
130
SRE
34
TMO
64
VSAC
46
WPM
38
WSFS
48
XYF
60
Exchanges
Amex
1
Nasdaq
130
Nyse
55
Crawled Date
2024 - 01 - 16
2
2023 - 11 - 21
2
2023 - 09 - 22
2
2023 - 07 - 21
2
2023 - 06 - 02
1
2023 - 06 - 01
1
2023 - 05 - 18
1
2023 - 05 - 16
2
2023 - 05 - 09
2
2023 - 05 - 05
1
2023 - 05 - 04
1
2023 - 05 - 03
8
2023 - 05 - 02
3
2023 - 05 - 01
8
2023 - 04 - 25
1
2023 - 04 - 19
1
2023 - 04 - 13
1
2023 - 04 - 10
1
2023 - 04 - 04
1
2023 - 03 - 21
1
2023 - 03 - 03
1
2023 - 02 - 27
1
2023 - 02 - 23
1
2023 - 02 - 09
1
2023 - 01 - 30
2
2023 - 01 - 26
1
2023 - 01 - 12
1
2022 - 12 - 15
1
2022 - 12 - 08
2
2022 - 11 - 29
1
2022 - 11 - 08
1
2022 - 11 - 02
1
2022 - 11 - 01
1
2022 - 10 - 05
1
2022 - 09 - 30
1
2022 - 09 - 28
1
2022 - 08 - 31
1
2022 - 08 - 24
2
2022 - 08 - 08
2
2022 - 07 - 27
1
2022 - 07 - 01
1
2022 - 06 - 29
2
2022 - 04 - 19
2
2022 - 04 - 07
1
2022 - 03 - 30
1
2022 - 02 - 23
1
2022 - 01 - 18
1
2021 - 12 - 21
1
2021 - 11 - 26
1
2021 - 11 - 18
2
2021 - 11 - 11
1
2021 - 11 - 10
1
2021 - 11 - 09
1
2021 - 11 - 08
1
2021 - 11 - 05
1
2021 - 10 - 29
1
2021 - 10 - 21
1
2021 - 10 - 20
1
2021 - 10 - 07
1
2021 - 10 - 05
1
Crawled Time
00:00
103
00:20
20
01:00
84
02:00
47
03:00
34
04:00
27
04:20
14
05:00
65
06:00
103
07:00
120
08:00
91
08:20
4
09:00
92
10:00
88
11:00
218
12:00
255
12:15
9
12:20
70
12:30
41
13:00
217
13:15
8
13:20
59
13:30
56
14:00
184
14:15
12
14:20
48
14:30
56
15:00
152
15:15
6
15:20
50
15:30
66
16:00
181
16:20
26
17:00
189
18:00
148
19:00
120
20:00
118
20:20
18
21:00
159
22:00
130
23:00
102
Source
investors.biomarin.com
2
spacfeed.com
18
www.biospace.com
30
www.globenewswire.com
13
www.inovio.com
1
www.interpublic.com
1
www.prnewswire.com
65
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Snynf
crawled time :
22:00
save search
Pneumococcal Vaccine Market, 41% of Growth to Originate from North America, Technavio
Published:
2024-04-16
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
0.63%
|
O:
0.12%
H:
0.51%
C:
0.51%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
0.52%
|
O:
1.0%
H:
0.19%
C:
-0.47%
pneumococcal
vaccine
growth
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-0.29%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
$140.15
3.58%
-4.19%
560
|
Health Technology
|
-0.47%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
News
|
$39.52
-0.13%
0.0%
2.8M
|
Health Technology
|
-0.85%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
1.39%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-1.62%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
|
News
S
|
$90.47
-0.44%
-0.43%
1.3M
|
Health Technology
|
-0.46%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.2M
|
Health Technology
|
-0.68%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
$264.07
-0.59%
-0.59%
1.6M
|
Health Technology
|
0.54%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
Published:
2024-04-09
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
TMO
|
News
|
$547.25
-1.32%
-1.51%
1.2M
|
Health Technology
|
-7.12%
|
O:
-2.01%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
-0.85%
|
O:
-0.71%
H:
0.0%
C:
0.0%
BIO
|
$290.86
-0.65%
-1.0%
140K
|
Health Technology
|
-13.77%
|
O:
-2.71%
H:
0.52%
C:
0.24%
AVTR
|
$24.38
-0.89%
-1.93%
5.1M
|
Process Industries
|
-4.87%
|
O:
-1.7%
H:
1.08%
C:
0.55%
THMO
|
$0.63
-10.14%
-11.23%
36K
|
Health Technology
|
-24.22%
|
O:
4.99%
H:
2.78%
C:
-2.1%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-2.99%
|
O:
-0.32%
H:
0.0%
C:
0.0%
global
growth
market
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-03-27
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
$20.2
0.65%
-14.18%
290
|
Health Technology
|
-4.72%
|
O:
0.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-7.02%
|
O:
-1.17%
H:
0.0%
C:
-0.89%
AZNCF
|
$140.15
3.58%
-4.19%
560
|
Health Technology
|
0.45%
|
O:
0.89%
H:
0.78%
C:
0.78%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.13%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
-2.92%
|
O:
0.52%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
-7.89%
|
O:
0.02%
H:
0.51%
C:
-0.3%
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
-9.37%
|
O:
0.26%
H:
2.03%
C:
1.57%
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
-9.11%
|
O:
0.36%
H:
0.72%
C:
0.61%
ABT
|
News
|
$105.9
-3.03%
0.38%
11M
|
Health Technology
|
-3.69%
|
O:
1.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-7.26%
|
O:
-0.96%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.2M
|
Health Technology
|
0.01%
|
O:
-0.12%
H:
0.25%
C:
-0.63%
AMGN
|
$264.07
-0.59%
-0.59%
1.6M
|
Health Technology
|
-6.76%
|
O:
0.54%
H:
0.0%
C:
0.0%
abbvie
set
canada
key
market
Biopharma Layoff Tracker 2024: Perrigo, Denali, Galapagos and More Cut Staff
Published:
2024-02-28
(Crawled : 22:00)
- biospace.com/
RLYB
|
News
|
$1.76
-2.22%
-3.45%
470K
|
|
-18.87%
|
O:
0.94%
H:
10.98%
C:
3.74%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-9.52%
|
O:
0.67%
H:
0.0%
C:
0.0%
VXRT
|
News
|
$0.8661
-3.16%
-3.1%
1.1M
|
Health Technology
|
-31.5%
|
O:
5.51%
H:
0.0%
C:
-3.36%
TXMD
|
News
|
$1.89
-0.53%
-1.06%
29K
|
Health Technology
|
-19.57%
|
O:
0.0%
H:
1.7%
C:
0.85%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-4.63%
|
O:
-0.63%
H:
0.0%
C:
0.0%
PTCT
|
News
|
$25.16
-0.51%
-0.4%
670K
|
Health Technology
|
-11.13%
|
O:
-0.46%
H:
2.61%
C:
0.07%
NKTR
|
News
|
$1.35
-9.4%
-10.78%
3.1M
|
Health Technology
|
80.0%
|
O:
2.67%
H:
1.3%
C:
-6.49%
MOR
|
News
|
$18.04
0.5%
0.44%
400K
|
Health Technology
|
2.09%
|
O:
-0.45%
H:
0.34%
C:
-0.06%
GLPG
|
News
|
$29.22
-0.92%
-0.82%
180K
|
Health Technology
|
-20.47%
|
O:
-0.11%
H:
0.25%
C:
-1.69%
AMRN
|
News
|
$0.9171
2.37%
3.14%
720K
|
Health Technology
|
-31.19%
|
O:
-0.74%
H:
0.0%
C:
-1.49%
GOOGL
|
News
|
$155.47
0.69%
0.68%
18M
|
Technology Services
|
11.95%
|
O:
-0.71%
H:
0.08%
C:
-1.1%
GOOG
|
News
S
|
$156.88
0.56%
0.56%
13M
|
Technology Services
|
11.98%
|
O:
-0.71%
H:
0.13%
C:
-1.2%
OCX
|
News
J
|
$2.59
-5.82%
4.89%
35K
|
Health Technology
|
-12.5%
|
O:
0.36%
H:
2.97%
C:
-0.36%
biopharma
Kneat Announces Record Revenue for Fourth Quarter and Full Year 2023
Published:
2024-02-21
(Crawled : 22:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-2.16%
|
O:
1.67%
H:
0.0%
C:
0.0%
year
revenue
Sanofi: Information concerning the total number of voting rights and shares - December 2023
Published:
2024-01-17
(Crawled : 22:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-9.12%
|
O:
0.1%
H:
0.76%
C:
0.76%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-10.71%
|
O:
-1.1%
H:
1.63%
C:
1.59%
total
AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032) | DelveInsight `
Published:
2024-01-16
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
18.31%
|
O:
0.77%
H:
0.17%
C:
-1.65%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-10.76%
|
O:
0.45%
H:
0.06%
C:
-0.5%
RGNX
|
News
|
$17.03
-2.69%
-2.88%
410K
|
Health Technology
|
11.53%
|
O:
-0.13%
H:
0.0%
C:
-7.15%
ADVM
|
$11.35
-2.24%
-2.56%
68K
|
Health Technology
|
1338.66%
|
O:
-0.69%
H:
2.32%
C:
-0.12%
therapy
growth
study
market
Sjogren's Syndrome Market to Register Sustainable Growth During the Study Period (2019-2032), Predicts DelveInsight | Key Players - Horizon Therapeutics, Dompe Farmaceutici, MorphoSys, Resolve Therapeutics, Novartis, Johnson & Johnson
Published:
2024-01-16
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-10.78%
|
O:
-1.83%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-10.59%
|
O:
-1.02%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
18.31%
|
O:
0.77%
H:
0.17%
C:
-1.65%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-10.76%
|
O:
0.45%
H:
0.06%
C:
-0.5%
IMAB
|
$1.81
1.12%
1.1%
390K
|
Health Technology
|
-2.69%
|
O:
-1.08%
H:
0.0%
C:
-8.42%
resolve
key
growth
study
market
Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar
Published:
2024-01-11
(Crawled : 22:00)
- prnewswire.com
RYZB
|
$62.49
0.03%
280K
|
|
1.11%
|
O:
0.21%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-11.92%
|
O:
0.71%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
18.1%
|
O:
0.39%
H:
0.91%
C:
0.74%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-11.9%
|
O:
0.06%
H:
0.0%
C:
0.0%
tumors
key
advanced
growth
market
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published:
2024-01-10
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-10.95%
|
O:
1.1%
H:
0.0%
C:
0.0%
NVO
|
News
|
$124.53
0.88%
0.19%
2.5M
|
Health Technology
|
14.59%
|
O:
-0.33%
H:
0.35%
C:
-1.5%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
19.13%
|
O:
0.67%
H:
0.85%
C:
0.21%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-11.29%
|
O:
0.69%
H:
0.0%
C:
0.0%
ALDX
4
|
$3.97
2.58%
2.76%
600K
|
Health Technology
|
15.87%
|
O:
-1.8%
H:
0.46%
C:
-2.44%
companies
therapeutics
growth
market
Achondroplasia Treatment Drug Market to Register Positive Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Ascendis Pharma, QED Therapeutics (BridgeBio), Novartis, Sanofi, RIBOMIC
Published:
2024-01-09
(Crawled : 22:00)
- prnewswire.com
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-11.17%
|
O:
0.13%
H:
0.0%
C:
0.0%
drug
companies
achondroplasia
positive
treatment
key
therapeutics
growth
market
Active Pharmaceutical Ingredients Market is to grow by USD 86.47 billion from 2023 to 2028, Asia to account for 52% of market growth - Technavio
Published:
2024-01-05
(Crawled : 22:00)
- prnewswire.com
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$164.25
1.05%
0.26%
3M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
0.65%
-14.18%
290
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
News
|
$547.25
-1.32%
-1.51%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
AAPL
|
News
S
|
$168.0
-0.82%
-0.82%
43M
|
Electronic Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$93.08
-0.13%
0.13%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
GOOG
|
News
S
|
$156.88
0.56%
0.56%
13M
|
Technology Services
|
Email alert
Add to watchlist
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.1
-0.18%
-0.23%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
GOOGL
|
News
|
$155.47
0.69%
0.68%
18M
|
Technology Services
|
Email alert
Add to watchlist
active
asia
growth
market
Fluzone High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
Published:
2024-01-03
(Crawled : 22:00)
- biospace.com/
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-7.3%
|
O:
0.49%
H:
0.0%
C:
-0.26%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-6.62%
|
O:
1.38%
H:
0.0%
C:
0.0%
vaccine
influenza
Metastatic Castration-Resistant Prostate Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 7.5% During the Study Period (2019-2032), Estimates DelveInsight
Published:
2023-12-20
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-3.34%
|
O:
-0.1%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-7.46%
|
O:
-1.87%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
31.67%
|
O:
0.21%
H:
0.63%
C:
0.1%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-5.45%
|
O:
-0.08%
H:
0.0%
C:
0.0%
cancer
growth
study
market
Autism Spectrum Disorder Therapeutics Market to Grow at a Substantial Growth Rate During the Study Period (2019-2032), Assesses DelveInsight | Key Players in the Market - Otsuka, Jazz, MapLight, Vanda, ACADIA, AbbVie, Axial, Roche, Yamo
Published:
2023-12-19
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-3.41%
|
O:
-0.39%
H:
1.49%
C:
0.32%
SUPN
|
$29.0
-1.46%
-1.59%
390K
|
Health Technology
|
3.17%
|
O:
-0.11%
H:
0.82%
C:
-2.31%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-5.26%
|
O:
0.21%
H:
0.0%
C:
0.0%
AXSM
|
$69.71
1.31%
1.26%
340K
|
Health Technology
|
-6.82%
|
O:
-0.46%
H:
0.0%
C:
-4.03%
ACAD
|
News
|
$17.19
0.64%
0.7%
690K
|
Health Technology
|
-42.88%
|
O:
-0.17%
H:
0.76%
C:
-3.42%
therapeutics
growth
study
market
In-Depth Market Analysis of Rare Genetic Disorders: Familial Chylomicronemia Syndrome (FCS), Netherton Syndrome, and Acromegaly | Key Insights by DelveInsight
Published:
2023-12-18
(Crawled : 22:00)
- prnewswire.com
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-4.83%
|
O:
0.45%
H:
0.0%
C:
0.0%
OPK
|
$1.25
3.31%
3.59%
3.5M
|
Health Technology
|
-18.83%
|
O:
0.65%
H:
4.52%
C:
4.52%
ARWR
|
$22.53
-4.82%
-5.11%
860K
|
Health Technology
|
-15.28%
|
O:
1.57%
H:
6.03%
C:
5.71%
rare
genetic
market
Biden, Big Pharma Increasingly at Loggerheads in Run-Up to 2024 Election
Published:
2023-12-15
(Crawled : 22:00)
- biospace.com/
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-4.53%
|
O:
-0.93%
H:
0.0%
C:
0.0%
pharma
Metastatic Prostate Cancer Market to Exhibit Positive Growth at a CAGR of 22% and 7.5% for mHSPC and mCRPC, respectively During the Study Period (2019-2032), Assesses DelveInsight
Published:
2023-12-13
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-3.35%
|
O:
0.25%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
28.73%
|
O:
1.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-4.53%
|
O:
0.0%
H:
0.0%
C:
0.0%
positive
cancer
growth
study
market
Chronic Inflammatory Demyelinating Polyneuropathy Market to Register Positive Growth During the Study Period (2019-2032), Evaluates DelveInsight | Key Companies to Watch Out - Octapharma, argenx, Immunovant Sciences, Sanofi, Janssen, Takeda
Published:
2023-12-12
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-1.13%
|
O:
-0.06%
H:
2.36%
C:
2.36%
UCBJY
|
$64.07
1.2%
-4.38%
72K
|
Manufacturing
|
53.09%
|
O:
-0.62%
H:
1.01%
C:
1.01%
JNJ
|
News
|
$144.77
0.22%
0.22%
7.9M
|
Health Technology
|
-6.51%
|
O:
-0.71%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-2.74%
|
O:
-0.27%
H:
2.28%
C:
2.16%
CPRX
|
$16.0
2.96%
2.81%
1M
|
Health Technology
|
16.4%
|
O:
-0.37%
H:
5.49%
C:
5.49%
companies
positive
growth
study
market
← Previous
1
2
3
4
5
6
7
Next →
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.82
139.47%
56.82%
220M
|
Health Technology
SINT
|
$0.0373
62.88%
37.26%
460M
|
Health Technology
WISA
4
|
$9.25
51.64%
34.27%
64M
|
Electronic Technology
EDBL
|
News
|
$6.66
46.37%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
600K
|
Manufacturing
TCON
|
$2.29
33.92%
26.61%
1.8M
|
Health Technology
TIRX
|
$0.4848
7.49%
24.58%
5.9M
|
SRFM
4
|
$0.3859
-12.3%
23.84%
660K
|
n/a
KZIA
|
$0.3442
18.28%
23.42%
290K
|
Health Technology
CTM
|
$0.2201
-2.31%
22.67%
48K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.